Abstract
The preliminary survival data are reported for the second non-Hodgkin lymphoma trial (LR-11, 20751) of the EORTC (European Organization for Research and Treatment on Cancer). A total of 576 patients were collected. Pathology was reviewed for 2 3 of the patients according to the Rappaport, the Lukes-Collins and the Kiel classification. Survival is correlated to pathology, stage and treatment.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Radiation Oncology, Biology, Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
